The US Food Drug Administration is seeking feedback on a procedure that it expects will help its devices unit clarify and communicate to stakeholders more quickly any changes in its regulatory expectations that could affect data submitted as part of a pre-market submission or an investigational device exemption1,2
...
Please Login to read the full article.
